The Scientist Who Bet Everything on a Fragile Molecule: How Katalin Karikó’s Gamble Changed Medicine Forever
Share
Katalin Karikó is a Hungarian-born biochemist who spent 40 years chasing an idea that many thought wasn’t worth it.
What was her idea? She theorized that a tiny, fragile molecule called messenger RNA—or mRNA—could be used to treat diseases. mRNA is a type of molecule that carries instructions from DNA to a cell’s protein-making machinery. In essence, mRNA tells the cell what proteins to make. Most people thought it was too unstable and risky to become useful in medicine, but Karikó believed it could be the key to fighting diseases from the inside out. She imagined a future where mRNA could turn our cells into tiny factories, producing treatments that could stop diseases like heart disease, cancer, or even a new virus that the world had never seen before.
For years, she labored in underfunded labs, was rejected by funding agencies, and was even demoted from her job—but she never gave up. Then, in the middle of the COVID-19 pandemic, the world’s attention turned to a breakthrough that Karikó had been working on for decades: mRNA technology. This once-dismissed molecule became the foundation for the COVID-19 vaccines which have saved millions of lives. It wasn’t just a scientific success but the ultimate vindication of Karikó’s relentless determination.
The Early Years: A Girl with Big Dreams
Katalin Karikó was born in 1955 in Szolnok, a small village in Hungary. As a young girl, she was always curious about the world. Growing up in a modest home, Karikó didn’t have access to fancy equipment or labs, but she had something more important: a love of learning and a dream to make a difference.
Karikó earned her undergraduate degree in biology and her PhD in biochemistry from the University of Szeged, after which, she continued her research at the Biological Research Center of the Hungarian Academy of Sciences. Then, in 1985, she migrated to the United States.
The Struggles of an mRNA Pioneer
Once in the U.S., Karikó’s scientific career didn’t take off as she had hoped. She worked at Temple University and the Uniformed Services University of the Health Sciences. Later, she worked at the University of Pennsylvania School of Medicine where she focused on using mRNA to treat diseases. Karikó believed that if you could deliver synthetic mRNA into cells, you could instruct them to make any protein you wanted. These included proteins that could fight off viruses, repair damaged tissues, or even attack cancer cells.
mRNA technology was still in its infancy. Scientists knew how to make synthetic mRNA, but they couldn’t figure out how to use it in the body. mRNA was fragile and easily destroyed by the immune system before it could do its job. After years of struggling to secure funding, in 1995, Karikó was informed that she would not be promoted to a position as a research assistant professor at Penn. To most people, that would have been the end, but not for Karikó. She refused to give up on her vision.
A Breakthrough Collaboration: Teaming Up with Drew Weissman
Everything changed when Karikó met Drew Weissman, an immunologist at Penn. Weissman was intrigued by Karikó’s ideas. Together, they worked to find a way to enable mRNA to enter the body without causing an immune reaction. What was their solution? They modified the mRNA in a way that made it invisible to the immune system while still allowing it to deliver its instructions to cells.
With this breakthrough, mRNA could be used safely in the body for the first time. The two scientists were successful in their endeavor and published their findings in 2005, but the scientific community was still skeptical. mRNA had been considered a failure for so long that many researchers didn’t believe it could work, even with Karikó and Weissman’s discovery.
The COVID-19 Pandemic: mRNA’s Moment to Shine
Years passed, and Karikó’s work continued to fly under the radar. She became an adjunct professor of neurosurgery at Penn and later joined BioNTech, a German company where she became a senior vice president. She continued to study the potential uses of mRNA, including being used as vaccines for viruses, like the Zika virus, and treatments for heart disease and cancer. However, it wasn’t until 2020, with the arrival of the COVID-19 pandemic, that the world finally realized the importance of her work.
As COVID-19 spread rapidly across the globe, scientists raced to develop a vaccine. Traditional vaccines, which use weakened or inactivated viruses, were taking too long to develop and produce. In contrast, mRNA technology offered a faster solution. By delivering synthetic mRNA that instructed cells to produce a piece of the virus (the spike protein), the immune system could be trained to recognize and fight the virus, without ever exposing the body to the actual virus.
In a matter of months, the mRNA vaccines developed by BioNTech (in partnership with Pfizer) and Moderna were ready for testing. The mRNA vaccines were not only effective—they were game-changers. Administering the COVID-19 vaccines marked a turning point in the fight against the pandemic. For Karikó, it was the moment she had been waiting for her entire career.
Redefining Failure: Karikó’s Counterintuitive Success
Katalin Karikó’s story isn’t just about the success of mRNA technology. It’s about redefining what it means to fail. For decades, Karikó was told that her ideas wouldn’t work, that mRNA was too unstable to ever be useful in medicine. She faced rejection after rejection, but instead of seeing failure as a reason to give up, she saw it as part of the process.
It was the very “weaknesses” of mRNA—its fragility and instability—that made it so powerful in the end. Unlike traditional vaccines, which can take years to develop, mRNA vaccines can be designed and produced quickly because they don’t require the actual virus to be grown in the lab. Also, because mRNA doesn’t stick around in the body for long, it’s less likely to cause side effects.
Karikó’s ability to see potential where others saw problems is what made her a visionary. She embraced the challenge of working with a difficult molecule because she believed it could do something extraordinary…and she was right.
Recognition at Last: The Nobel Prize and Beyond
In 2021, Karikó’s role in developing mRNA technology was finally recognized on the global stage. Karikó, along with Drew Weissman, received several prestigious awards for their contributions, including the Lasker-DeBakey Clinical Medical Research Award in 2021 and the Nobel Prize in 2023.
A Lesson in Persistence: Karikó’s Enduring Impact
Katalin Karikó’s story is a testament to the power of persistence. She worked in underfunded labs and faced constant rejection, but she never lost faith in her ideas. She believed that mRNA research could change the world, and she was willing to bet her entire career on that belief.
Today, mRNA technology is being used, not only to fight COVID-19 but to develop treatments for diseases that have long been untreatable. It’s all thanks to a scientist who refused to give up on a molecule that no one else believed in.
The next time you hear about mRNA vaccines or read about new advances in medicine, remember Katalin Karikó. Her story shows us that science isn’t just about facts and experiments; it’s about vision, perseverance, and the courage to chase ideas that others think are impossible.
Check out these resources to learn more about Katalin Karikó:
Garde, Damian. "The Story of mRNA: How a Once-Dismissed Idea Became a Leading Technology in the Covid Vaccine Race." STAT News, 10 Nov. 2020, www.statnews.com/2020/11/10/the-story-of-mrna-how-a-once-dismissed-idea-became-a-leading-technology-in-the-covid-vaccine-race/. Accessed 21 Oct. 2024.
Higgins-Dunn, Noah. "How mRNA Went from a Scientific Backwater to a Pandemic Crusher." Wired, www.wired.com/story/mrna-coronavirus-vaccine-pfizer-biontech/. Accessed 21 Oct. 2024.
La Roche, Julia. "Nobel Prize Winner Katalin Karikó was ‘Demoted 4 Times’ at Her Old Job. How She Persisted: ‘You Have to Focus on What’s Next’." CNBC, 6 Oct. 2023, www.cnbc.com/2023/10/06/nobel-prize-winner-katalin-karik-on-being-demoted-perseverance-.html. Accessed 21 Oct. 2024.
Rogers, Kara. "Katalin Karikó". Encyclopedia Britannica, 24 Sep. 2024, https://www.britannica.com/biography/Katalin-Kariko. Accessed 21 October 2024.